AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions

Adenoid Cystic CarcinomaMetastatic Adenoid Cystic Carcinoma

Interventions

DRUG

AL101

Given IV

PROCEDURE

Therapeutic Conventional Surgery

Undergo standard of care surgery

Trial Locations (1)

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER